| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |